The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-((1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)amino)isonicotinic acid ID: ALA5277662
Chembl Id: CHEMBL5277662
Max Phase: Preclinical
Molecular Formula: C14H12N4O2
Molecular Weight: 268.28
Associated Items:
Names and Identifiers Canonical SMILES: Cn1cc(Nc2cnccc2C(=O)O)c2cccnc21
Standard InChI: InChI=1S/C14H12N4O2/c1-18-8-12(9-3-2-5-16-13(9)18)17-11-7-15-6-4-10(11)14(19)20/h2-8,17H,1H3,(H,19,20)
Standard InChI Key: RBGNHCYGFBRIRO-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 268.28Molecular Weight (Monoisotopic): 268.0960AlogP: 2.41#Rotatable Bonds: 3Polar Surface Area: 80.04Molecular Species: ACIDHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.43CX Basic pKa: 4.02CX LogP: 1.88CX LogD: -0.72Aromatic Rings: 3Heavy Atoms: 20QED Weighted: 0.76Np Likeness Score: -0.78
References 1. Yang GJ, Wu J, Miao L, Zhu MH, Zhou QJ, Lu XJ, Lu JF, Leung CH, Ma DL, Chen J.. (2021) Pharmacological inhibition of KDM5A for cancer treatment., 226 [PMID:34555614 ] [10.1016/j.ejmech.2021.113855 ]